J A Pieper
Overview
Explore the profile of J A Pieper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pieper J
Pharmacotherapy
. 2001 Sep;
21(9 Pt 2):195S-208S.
PMID: 11560190
The death rate from coronary heart disease (CHD) declined by 25% in the United States during 1987-1997, but the actual number of deaths fell by only 9%. Modifiable risk factors...
2.
3.
McCune J, Lindley C, Decker J, Williamson K, Meadowcroft A, Graff D, et al.
J Clin Pharmacol
. 2001 Jul;
41(7):723-31.
PMID: 11452704
Gender-based differences in cytochrome P450 (CYP) activity may occur due to endogenous hormonal fluctuations with the menstrual cycle, which are altered by oral contraceptives. This study assessed the average activity...
4.
Scripture C, Pieper J
Clin Pharmacokinet
. 2001 May;
40(4):263-81.
PMID: 11368292
Fluvastatin, the first fully synthetic HMG-CoA reductase inhibitor, has been shown to reduce cholesterol in patients with hyperlipidaemia, to prevent subsequent coronary events in patients with established coronary heart disease,...
5.
Graff D, Williamson K, Pieper J, Carson S, Adams Jr K, Cascio W, et al.
J Clin Pharmacol
. 2001 Feb;
41(1):97-106.
PMID: 11225566
The objective of this study was to examine the pharmacokinetic and pharmacodynamic consequences of concomitant administration of fluoxetine and carvedilol in heart failure patients. Fluoxetine (20 mg) or matching placebo...
6.
Meadowcroft A, Williamson K, Patterson J, Hinderliter A, Pieper J
J Clin Pharmacol
. 1999 Apr;
39(4):418-24.
PMID: 10197301
Losartan is an angiotensin II receptor antagonist that is metabolized by CYP2C9 and CYP3A4 to a more potent antihypertensive metabolite, E3174. Interaction studies with inhibitors of CYP3A4 have not demonstrated...
7.
Hilleman D, Miller M, Parker R, Doering P, Pieper J
Pharmacotherapy
. 1998 Dec;
18(6 Pt 2):138S-145S.
PMID: 9855346
Objectives: To review management and dosing guidelines for amiodarone therapy, and discuss the drug's adverse event profile. Methods: Review of relevant studies and reports. Results: Amiodarone is a highly effective...
8.
Williamson K, Patterson J, McQueen R, Adams Jr K, Pieper J
Clin Pharmacol Ther
. 1998 Apr;
63(3):316-23.
PMID: 9542475
Background: Losartan is metabolized by CYP2C9 and CYP3A4 to an active metabolite, E3174, which has greater antihypertensive activity than the parent compound. Coadministered drugs that inhibit or induce metabolic processes...
9.
Meadowcroft A, Williamson K, Patterson J, Pieper J
Pharmacotherapy
. 1997 Jul;
17(4):637-9.
PMID: 9250542
No abstract available.
10.